The solubility study of drugs in
aqueous and organic solvents has
practical importance in pharmaceutical industries. In this research
work, the solubilities of satranidazole (SAT) were determined in 18
monosolvents, namely, methanol (MeOH), ethanol (EtOH), 1-propanol
(1-PrOH), 2-propanol (2-PrOH), formamide, 1,4-dioxane, N,N-dimethyl formamide (DMF), N,N-dimethyl acetamide
(DMA), dimethyl sulfoxide (DMSO), N-methyl-2-pyrrolidone
(NMP), ethylene glycol (EG), propylene glycol (PG), 1,4-butanediol
(BDOH), glycerin, polyethylene glycol-200 (PEG-200), PEG-400, PEG-600,
and water, at five different temperatures (T = 293.2–313.2
K) and atmospheric pressure (p = 0.1 MPa). Experimental
solubilities expressed in the molar fraction of SAT were correlated
well with thermodynamic models including van’t Hoff model,
Apelblat model, Buchowski–Ksiazczak model, and polynomial empirical
model. The molar fraction solubility of SAT was recorded highest in
NMP (7.963 × 10–2 at T = 293.2
K) followed by DMSO, formamide, DMF, DMA, PEG-600, PEG-400, PEG-200,
1,4-dioxane, PG, EG, BDOH, glycerin, MeOH, EtOH, 1-PrOH, 2-PrOH, and
water as expected over the entire temperature range investigated.